Lilly to sell off drug for low blood sugar in deal worth up to $1.1B
Eli Lilly and Co. plans to sell its drug to treat low blood sugar to California-based Amphastar Pharmaceuticals in a deal that could be worth up to $1.1 billion.... Read More
Life Sciences
Purdue Ventures invests in cancer therapeutics firm
Purdue Ventures has invested $250,000 in TRIO Pharmaceuticals Inc., an antibody-based cancer therapeutics company founded by a Purdue University biophysics and structural biology alumnus. ... Read More
Indiana life sciences sector received $6.8B in investment
The state's life sciences sector accessed more than $6.8 billion in capital investment in 2022, according to a new report from BioCrossroads. The state's life sciences initiative said the investment will directly result in the creation of 3,000 new jobs.... Read More
Purdue-based biotech startup to hire 43 people at new Indy HQ
A biotech startup that has raised $6 million to develop a highly purified form of collagen used to support tissue generation plans to hire 43 people and stands to get a six-year tax abatement worth more than a quarter-million dollars.... Read More
Fort Wayne ortho firm receives key designation for knee system
Orthopedic implant manufacturer BioPoly LLC says it has received a Breakthrough Device designation from the U.S. Food and Drug Administration for its BioPoly Knee System. ... Read More
Lilly to invest another $1.6B in Boone County site, add 200 jobs
Eli Lilly and Co. says it will invest an additional $1.6 billion in a new drug manufacturing site in Boone County, bringing the total amount to $3.7 billion. Lilly said the expanded manufacturing capacity would create 200 more jobs.... Read More
Lilly to break ground on LEAP District plants
State and local officials will join executives from Eli Lilly and Co. (NYSE: LLY) on Monday to break ground on the company's manufacturing plants in the LEAP Innovation and Research District in Boone County.... Read More
Catalent expects ‘productivity issues’ to affect earnings
New Jersey-based Catalent Inc. (NYSE: CTLT) expects productivity issues at three of its facilities, including one in Bloomington, will "materially and adversely impact" its fiscal third quarter financial results, the company said Friday. ... Read More
VisionTech Angels invests in biotech firm focused on diabetes treatment
Indianapolis-based VisionTech Angels has invested $242,000 in Adipo Therapeutics, a pre-clinical stage company seeking to transform the treatment of type 2 diabetes and obesity through a subcutaneous injection.... Read More
Roche & Lilly team up to catch Alzheimer’s early
Two Indianapolis powerhouses are joining forces to improve how doctors diagnose Alzheimer's disease. Roche Diagnostics and Eli Lilly and Co. are working to create a routine blood test that could help spot the disease earlier.... Read More
Life sciences company secures $6M in Series A funding
Zionsville-based GeniPhys has completed a $6 million Series A round of funding, the company announced Wednesday. GeniPhys has developed a material known as Collymer, a highly-purified form of collagen that is used to support tissue generation.... Read More
Evonik to break ground on $220M Lafayette expansion
Germany-based Evonik will Wednesday break ground on the previously-announced $220 million expansion of its pharmaceutical production facility in Lafayette. The expansion is expected to create more than 80 jobs by the end of 2025.... Read More
Indiana sizing up possible bid for new federal life sciences hub
The Advanced Research Projects Agency for Health, or ARPA-H, is looking for cities that can help design biomedical products, enhance clinical trials and bring new health products to market.... Read More
Elanco’s shares slip to all-time low after Moody’s downgrade
Shares of Elanco Animal Health dropped 4% on Wednesday to a new all-time low after Moody’s Investor Service downgraded the company’s credit rating. Moody’s action pushed Elanco’s credit rating further into “junk bond” territory.... Read More
BioCrossroads names two new executives
BioCrossroads, Indiana’s initiative to grow the life sciences sector, has added two new people to the organization’s leadership team. ... Read More
Planners recommend approval of Lilly manufacturing site in Boone County
The Lebanon Plan Commission voted unanimously Monday to recommend approval of Eli Lilly and Co.’s development plan for two manufacturing facilities in Boone County. The proposed $2.1 billion Lilly manufacturing campus north of Lebanon will...... Read More
State medical institute lands $38M grant from feds
A medical partnership involving some of Indiana’s biggest universities has received nearly $38 million to continue its work taking laboratory and clinical discoveries and translating them into treatments for patients. ... Read More
Notre Dame battles rising teen suicides with earbud device, $4M grant
Suicides are climbing faster among young people than adults, triggering alarm bells that “what we’re doing isn’t working,” says University of Notre Dame psychologist Theodore Beauchaine. He’s co-leading a mission to reinvent teen suicide prevention efforts.... Read More
Fishers biotech firm lands additional FDA approval
An Australian biotech company that has its U.S. headquarters in Fishers has received additional approval from the U.S. Food and Drug Administration. Telix Pharmaceuticals says its lead prostate cancer imaging product, Illuccix, is now authorized to...... Read More
IU researchers license AI tool to diagnose Alzheimer’s
Dr. Malaz Boustani, an esteemed brain doctor at the Indiana University School of Medicine, is haunted by the fact that he didn’t identify his own father’s Alzheimer’s disease. “I think I’m a great brain doctor—and I missed it,” he says. ... Read More